Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
A phase 2 trial of Sacituzumab govitecan, Pembrolizumab, Cisplatin, Avelumab, Zimberelimab and Carboplatin in bladder & urothelial cancer, run by Gilead Sciences, active and no longer recruiting.
Overview
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread is a phase 2 interventional study registered as NCT03547973 by Gilead Sciences, with 502 participants enrolled, started 2018-08-13 and due to reach its primary completion in 2030-04. Interventions recorded: Sacituzumab Govitecan-hziy, Pembrolizumab, Cisplatin, Avelumab, Zimberelimab and Carboplatin.
Similar pages
not linked directly; found by shared links- TrialA Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)
Shares Avelumab, Sacituzumab govitecan, Bladder & urothelial cancer and the tag pipeline.
- TrialStudy of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors
Shares Gilead Sciences (incl. Kite), Sacituzumab govitecan, Bladder & urothelial cancer and the tag pipeline.
- TrialStudy of Pembrolizumab (MK-3475) Monotherapy Versus Sacituzumab Govitecan in Combination With Pembrolizumab for Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-3475-D46)
Shares Gilead Sciences (incl. Kite), Sacituzumab govitecan, Pembrolizumab and the tag pipeline.
- TrialStudy BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
Shares Cisplatin, Carboplatin, Bladder & urothelial cancer, Pembrolizumab and the tag pipeline.
- TrialStudy of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors
Shares Gilead Sciences (incl. Kite), Sacituzumab govitecan and the tag pipeline.
- TrialStudy of Sacituzumab Govitecan in Patients With Solid Tumor
Shares Gilead Sciences (incl. Kite), Sacituzumab govitecan and the tag pipeline.
- TrialDisitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
Shares Cisplatin, Carboplatin, Bladder & urothelial cancer, Pembrolizumab and the tag pipeline.
- TrialStudy of Sacituzumab Govitecan in Chinese Patients With Metastatic Triple-negative Breast Cancer Who Received at Least Two Prior Treatments
Shares Gilead Sciences (incl. Kite), Sacituzumab govitecan and the tag pipeline.